PureTech Health plc

PRTC.L: LSE
32Total

Lowest reading is at 10 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Robert Lyne J.D., L.L.B.

Market Cap

280.49 Million GBp

Sector

Healthcare

Website

https://www.puretechhealth.com

Last Update

28/09/2026, 02:53:57

Description

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Read More

Strongest readings

  • ✔Share count has been falling at 5.44% per year
  • ✔Debt is low at 0.06 times equity

Weakest readings

  • ✘Price-to-earnings of 151.6 is above the market average of 19.6
  • ✘Income is not covering expenditure and investment (free cashflow -0.34 per share)
  • ✘Earnings are negative at -0.46 per share
  • ✘Priced well above the cashflow it produces (value score 10 out of 100)

Key Figures

StatusMetricValueReadingMarket avg
✘
Price / earnings (TTM)
151.61x
19.60x
✘
Margin of safety (DCF)
2.09%
17.95%
✘
Revenue growth (5y average)
7.97%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✔
Share count, per year
-5.44%
0.00%
✘Return on capital employed-13.34%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

10 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
✘
Price / earnings
151.61x
19.60x
✘Free cashflow yield-22.50%
4.70%
Price / earnings growthN/A1.50x
Price / book73.91x
—
✘
Margin of safety
2.09%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Estimated intrinsic value of 116.79 GBp is above the current price of 114.40 GBp

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: N/A✘

Current Price: 114.4 GBp

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

41 / 100

Growing more slowly than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
7.97%
10.97%
Earnings growthN/A14.48%
Cashflow growthN/A12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Health

    39 / 100

    Balance sheet is stretched on several measures.

    Measured on Leverage and capital, Funding and liquidity, Earnings quality.

    StatusMetricValueReadingThreshold
    ✘Altman-Z score0.00
    3.00
    Piotroski scoreN/A5.00
    ✔Debt / equity0.06x
    0.80x
    ✔Current ratio6.59x
    1.00x
    ✘Interest coverage-1.42x
    2.50x
    ✘Free cashflow / debt0.00x
    0.15x
    ✔Debt / capital0.06x
    1.00x

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘Income is not covering expenditure and investment (free cashflow -0.34 per share)

    Management

    40 / 100

    Returns on capital are below the market.

    StatusMetricValueReadingMarket avg
    ✘Return on equity-35.90%
    15.00%
    ✘Return on capital employed-13.34%
    10.00%
    Return on assets-20.52%
    —
    Free cashflow return on capital-17.43%
    —
    ✔Return on capital, 5y change5.43%
    0.00%
    ✔
    Share count, per year
    -5.44%
    0.00%
    ✘Share count, recent1.82%
    0.00%
    ✘Realized buyback return-57.20%
    0.00%
    ✔Goodwill erosion / equity0.00%
    2.00%
    Price volatility, 5 year41.58%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘Shares were repurchased while the value score was only 10 out of 100

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    PRTC.L

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    PureTech Health plc

    Currency

    GBp

    Beta

    0.778

    Vol Avg

    711241

    Ceo

    Mr. Robert Lyne J.D., L.L.B.

    Cik

    Cusip

    Exchange

    LSE

    Full Time Employees

    90

    Industry

    Biotechnology

    Sector

    Healthcare

    Ipo Date

    Address

    6 Tide Street

    City

    Boston

    State

    MA

    Country

    United States

    Zip

    02210

    Phone

    617 482 2333

    Analysis Last Updated

    28/09/2026, 02:53:57

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies